Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)
M Andrew, G Jayaraman - Carbohydrate Research, 2021 - Elsevier
The viral infection caused by SARS-CoV-2 has increased the mortality rate and engaged
several adverse effects on the affected individuals. Currently available antiviral drugs have …
several adverse effects on the affected individuals. Currently available antiviral drugs have …
[HTML][HTML] The antiviral activity of bacterial, fungal, and algal polysaccharides as bioactive ingredients: potential uses for enhancing immune systems and preventing …
W Chaisuwan, Y Phimolsiripol, T Chaiyaso… - Frontiers in …, 2021 - frontiersin.org
Viral infections may cause serious human diseases. For instance, the recent appearance of
the novel virus, SARS-CoV-2, causing COVID-19, has spread globally and is a serious …
the novel virus, SARS-CoV-2, causing COVID-19, has spread globally and is a serious …
What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms
Abstract Background Coronavirus disease 19 (COVID-19) is the disease caused by SARS-
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …
CoV-2, a highly infectious member of the coronavirus family, which emerged in December …
The efficacy and safety of remdesivir alone and in combination with other drugs for the treatment of COVID-19: A systematic review and meta-analysis
C Chen, J Fang, S Chen, MJN Rajaofera, X Li… - BMC Infectious …, 2023 - Springer
Background Remdesivir is considered to be a specific drug for treating coronavirus disease
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …
2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir …
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects
MT Kelleni - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
Introduction Mediators of immunity and inflammation are playing a crucial role in COVID-19
pathogenesis and complications as demonstrated by several genetic and clinical studies …
pathogenesis and complications as demonstrated by several genetic and clinical studies …
[HTML][HTML] SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
S Saifi, V Ravi, S Sharma, A Swaminathan… - Genomics, 2022 - Elsevier
The global COVID-19 pandemic continues due to emerging Severe Acute Respiratory
syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC). Here, we performed …
syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC). Here, we performed …
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study
R Sirijatuphat, W Manosuthi… - Emerging Microbes & …, 2022 - Taylor & Francis
We investigated Favipiravir (FPV) efficacy in mild cases of COVID-19 without pneumonia
and its effects towards viral clearance, clinical condition, and risk of COVID-19 pneumonia …
and its effects towards viral clearance, clinical condition, and risk of COVID-19 pneumonia …
Beyond vaccines: clinical status of prospective COVID-19 therapeutics
S Kumar, DM Çalışkan, J Janowski, A Faist… - Frontiers in …, 2021 - frontiersin.org
Since November 2019 the SARS-CoV-2 pandemic has caused nearly 200 million infection
and more than 4 million deaths globally (Updated information from the World Health …
and more than 4 million deaths globally (Updated information from the World Health …
Corticosteroids: A boon or bane for COVID-19 patients?
Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …
Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients-a hypothetical study
A Carta, C Conversano - BMC Health Services Research, 2021 - Springer
Abstract Background Sars-Cov-2 is a novel corona virus associated with significant
morbidity and mortality. Remdesivir and Dexamethasone are two treatments that have …
morbidity and mortality. Remdesivir and Dexamethasone are two treatments that have …